Pursuant to Regulation 30 read with Schedule III and Regulation 46(2)(oa) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, J.B. Chemicals & Pharmaceuticals has informed that it enclosed transcript of Conference Call which was scheduled for Investors and Analysts on November 8, 2023 at 3.30 pm IST in relation to results and developments for the second quarter ended on September 30, 2023. The same will also be available on the website of the Company www.jbpharma.com.
The above information is a part of company’s filings submitted to BSE.
